ArticleNeuro-oncology2022

BOLD asynchrony: An imaging biomarker of tumor burden in IDH-mutated gliomas.

Behroze Adi Vachha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.